Molecular mechanisms of curcumin action: Gene expression

BioFactors

Volumn 39, Issue 1, 2013, Pages 37-55

  Shishodia, Shishir ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Curcumin; Enzymes; Gene expression; Growth factors; Inflammatory cytokines; Molecular targets; Transcription factors

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ANDROGEN RECEPTOR; AROMATIC HYDROCARBON RECEPTOR; BETA CATENIN; CCAAT ENHANCER BINDING PROTEIN; CHEMOKINE RECEPTOR CXCR4; CONNECTIVE TISSUE GROWTH FACTOR; CURCUMIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEAT SHOCK TRANSCRIPTION FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN DERIVATIVE; NOTCH1 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLATELET DERIVED GROWTH FACTOR; STAT PROTEIN; THROMBOPLASTIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; WT1 PROTEIN;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; DNA BINDING MOTIF; DRUG PROTEIN BINDING; ENHANCER REGION; GENE EXPRESSION; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; WNT SIGNALING PATHWAY;

ANIMALS; ANTINEOPLASTIC AGENTS; CURCUMIN; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; MEDICINE, TRADITIONAL; NEOPLASMS; RECEPTORS, GROWTH FACTOR; TRANSCRIPTION FACTORS;

CURCUMA LONGA;

EID: 84874110671     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1041     Document Type: Review

References (243)

1. Shishodia, S., Sethi, G., and Aggarwal, B. B. ( 2005) Curcumin: getting back to the roots. Ann. N Y Acad. Sci. 1056, 206-217.
2. Aggarwal, B. B., Kumar, A., and Bharti, A. C. ( 2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23, 363-398.
3. Aggarwal, B. B. and Harikumar, K. B. ( 2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 41, 40-59.
4. Aggarwal, B. B., Sundaram, C., Malani, N., and Ichikawa, H. ( 2007) Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 595, 1-75.
5. Menon, V. P. and Sudheer, A. R. ( 2007) Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 595, 105-125.
6. An P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., and Aggarwal, B. B. ( 2008) Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett. 267, 133-164.
7. Lin, J. K. ( 2007) Molecular targets of curcumin. Adv. Exp. Med. Biol. 595, 227-243.
8. Yan, C., Jamaluddin, M. S., Aggarwal, B., Myers, J., and Boyd, D. D. ( 2005) Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol. Cancer Ther. 4, 233-241.
9. Aggarwal, B. B. and Shishodia, S. ( 2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71, 1397-1421.
10. Karin, M., Liu, Z., and Zandi, E. ( 1997) AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240-246.
11. Xia, Y., Makris, C., Su, B., Li, E., and Yang, J., et al. ( 2000) MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc. Natl. Acad. Sci. USA 97, 5243-5248.
12. Huang, M. T., Lysz, T., Ferraro, T., Abidi, T. F., and Laskin, J. D., et al. ( 1991) Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51, 813-819.
13. Chen, Y. R. and Tan, T. H. ( 1998) Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17, 173-178.
14. Bierhaus, A., Zhang, Y., Quehenberger, P., Luther, T., and Haase, M., et al. ( 1997) The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb. Haemost. 77, 772-782.
15. Dickinson, D. A., Iles, K. E., Zhang, H., Blank, V., and Forman, H. J. ( 2003) Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression. FASEB J. 17, 473-475.
16. Liang, G., Wolfgang, C. D., Chen, B. P., Chen, T. H., and Hai, T. ( 1996) ATF3 gene. Genomic organization, promoter, and regulation. J. Biol. Chem. 271, 1695-1701.
17. Jaiswal, A. S., Marlow, B. P., Gupta, N., and Narayan, S. ( 2002) Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21, 8414-8427.
18. Prasad, C. P., Rath, G., Mathur, S., Bhatnagar, D., and Ralhan, R. ( 2009). Potent growth suppressive activity of curcumin in human breast cancer cells: modulation of Wnt/beta-catenin signaling. Chem. Biol. Interact 181, 263-271.
19. Choi, H. Y., Lim, J. E., and Hong, J. H. ( 2010) Curcumin interrupts the interaction between the androgen receptor and Wnt/beta-catenin signaling pathway in LNCaP prostate cancer cells. Prostate Cancer Prostatic Dis. 13, 343-349.
20. Sundram, V., Chauhan, S. C., Ebeling, M., and Jaggi, M. ( 2012) Curcumin attenuates beta-catenin signaling in prostate cancer cells through activation of protein kinase D1. PLoS One 7, e35368.
21. Leow, P. C., Tian, Q., Ong, Z. Y., Yang, Z., and Ee, P. L ( 2010) Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/beta-catenin antagonists against human osteosarcoma cells. Invest New Drugs 28, 766-782.
22. Ahn, J., Lee, H., Kim, S., and Ha, T. ( 2010) Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling. Am. J. Physiol. Cell Physiol. 298, C1510-C1516.
23. Mahmoud, N. N., Carothers, A. M., Grunberger, D., Bilinski, R. T., Churchill, M. R., et al. ( 2000) Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21, 921-927.
24. Ryu, M. J., Cho, M., Song, J. Y., Yun, Y. S., Choi, I. W., et al. ( 2008) Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem. Biophys. Res. Commun. 377, 1304-1308.
25. Koleva, R. I., Ficarro, S. B., Radomska, H. S., Carrasco-Alfonso, M. J., and Alberta, J. A., et al. ( 2012) C/EBPalpha and DEK coordinately regulate myeloid differentiation. Blood 119, 4878-4888.
26. Wu, Y. V., Okada, T., DeCarolis, P., Socci, N., O'Connor, R., et al. ( 2012) Restoration of C/EBPalpha in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis. Genes Chromosomes Cancer 51, 313-327.
27. Chang, K. W., Hung, P. S., Lin, I. Y., Hou, C. P., Chen, L. K., et al. ( 2010) Curcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C/EBPalpha during oral cancer suppression. Int J Cancer 127, 9-20.
28. Ejaz, A., Wu, D., Kwan, P., and Meydani, M. ( 2009) Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J. Nutr. 139, 919-925.
29. Kim, C. Y., Le, T. T., Chen, C., Cheng, J. X., and Kim, K. H. ( 2011) Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion. J. Nutr. Biochem. 22, 910-920.
30. Marcu, M. G., Jung, Y. J., Lee, S., Chung, E. J., and Lee, M. J., et al. ( 2006) Curcumin is an inhibitor of p300 histone acetylatransferase. Med. Chem. 2, 169-174.
31. Balasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., and Siddappa, N. B., et al. ( 2004) Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 279, 51163-51171.
32. Huang, A. C., Chang, C. L., Yu, C. S., Chen, P. Y., and Yang, J. S., et al. ( 2011) Induction of apoptosis by curcumin in murine myelomonocytic leukemia WEHI-3 cells is mediated via endoplasmic reticulum stress and mitochondria-dependent pathways. Environ. Toxicol. doi: 10.1002/tox.20716.
33. Ng, A. P., Chng, W. J., and Khan, M. (2011) Curcumin sensitizes acute promyelocytic leukemia cells to unfolded protein response-induced apoptosis by blocking the loss of misfolded N-CoR protein. Mol. Cancer Res. 9, 878-888.
34. Jung, E. M., Park, J. W., Choi, K. S., Lee, H. I., Lee, and K. S., et al. ( 2006) Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. Carcinogenesis 27, 2008-2017.
35. Noh, H. J., Lee, S. J., Sung, E. G., Song, I. H., and Kim, J. Y., et al. (2012) CHOP down-regulates cFLIP(L) expression by promoting ubiquitin/proteasome-mediated cFLIP(L) degradation. J. Cell Biochem. doi: 10.1002/jcb.24242.
36. Pendurthi, U. R. and Rao, L. V. ( 2000) Suppression of transcription factor Egr-1 by curcumin. Thromb. Res. 97, 179-189.
37. Chen, A., Xu, J., and Johnson, A. C. ( 2006) Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25, 278-287.
38. Choi, B. H., Kim, C. G., Bae, Y. S., Lim, Y., and Lee, Y. H., et al. ( 2008) p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression. Cancer Res. 68, 1369-1377.
39. Balstad, T R., Carlsen, H., Myhrstad, M. C., Kolberg, M., and Reiersen, H., et al. Coffee, broccoli and spices are strong inducers of electrophile response element-dependent transcription in vitro and in vivo-studies in electrophile response element transgenic mice. Mol. Nutr. Food Res. 55, 185-197.
40. Dunsmore, K. E., Chen, P. G., and Wong, H. R. ( 2001) Curcumin, a medicinal herbal compound capable of inducing the heat shock response. Crit. Care Med. 29, 2199-2204.
41. Teiten, M. H., Reuter, S., Schmucker, S., Dicato, M., and Diederich, M. ( 2009) Induction of heat shock response by curcumin in human leukemia cells. Cancer Lett. 279, 145-154.
42. Lee, S. S., Tsai, C. H., Yang, S. F., Ho, Y. C., and Chang, Y. C. ( 2010) Hypoxia inducible factor-1alpha expression in areca quid chewing-associated oral squamous cell carcinomas. Oral Dis. 16, 696-701.
43. Shan, B., Schaaf, C., Schmidt, A., Lucia, K., and Buchfelder, M., et al. ( 2012) Curcumin suppresses HIF-1A synthesis and VEGFA release in pituitary adenomas. J. Endocrinol. 214, 389-398.
44. Li, M., Liu, C., Bin, J., Wang, Y., Chen, J., and Xiu, J., et al. ( 2011) Mutant hypoxia inducible factor-1alpha improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle. Microvasc. Res. 81, 26-33.
45. Wang, Z., Zhang, Y., Banerjee, S., Li, Y., and Sarkar, F. H. ( 2006) Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 106, 2503-2513.
46. Li, Y., Zhang, J., Ma, D., Zhang, L., and Si, M., et al. Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling. FEBS J. 279, 2247-2259.
47. Subramaniam, D., Ponnurangam, S., Ramamoorthy, P., Standing, D., Battafarano, R. J., et al. ( 2012) Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One 7, e30590.
48. Pickering, A. M., Linder, R. A., Zhang, H., Forman, H. J., and Davies, K. J. ( 2012) Nrf2-dependent induction of proteasome and Pa28alphabeta regulator are required for adaptation to oxidative stress. J. Biol. Chem. 287, 10021-10031.
49. Balogun, E., Hoque, M., Gong, P., Killeen, E., and Green, C.J., et al. ( 2003) Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J. 371, 887-895.
50. Rushworth, S. A., Ogborne, R. M., Charalambos, C. A., and O'Connell, M. A. ( 2006) Role of protein kinase C delta in curcumin-induced antioxidant response element-mediated gene expression in human monocytes. Biochem. Biophys. Res. Commun. 341, 1007-1016.
51. Banning, A., Deubel, S., Kluth, D., Zhou, Z., Brigelius-Flohe, R. ( 2005) The GI-GPx gene is a target for Nrf2. Mol. Cell Biol. 25, 4914-4923.
52. Carmona-Ramirez, I., Santamaria, A., Tobon-Velasco, J. C., Orozco-Ibarra, M., and Gonzalez-Herrera, I. G., et al. ( 2012) Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity. J. Nutr. Biochem. [Epub ahead of print]
53. He, H. J., Wang, G. Y., Gao, Y., Ling, W. H., and Yu, Z. W., et al. ( 2012) Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. World J. Diabetes 3, 94-104.
54. Mimche, P. N., Thompson, E., Taramelli, D., and Vivas, L. ( 2012) Curcumin enhances non-opsonic phagocytosis of Plasmodium falciparum through up-regulation of CD36 surface expression on monocytes/macrophages. J. Antimicrob. Chemother. 67, 1895-1904.
55. Aggarwal, B. B. ( 2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6, 203-208.
56. Baldwin, A.S. Jr. ( 2001) Series introduction: the transcription factor NF-kappaB and human disease. J. Clin Invest. 107, 3-6.
57. Pahl, H. L. ( 1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866.
58. Wang, C. Y., Mayo, M. W., and Baldwin, A. S. Jr. ( 1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274, 784-787.
59. Lee, H., Wu, M., La Rosa, F. A., Duyao, M. P., and Buckler, A. J., et al. ( 1995) Role of the Rel-family of transcription factors in the regulation of c-myc gene transcription and apoptosis of WEHI 231 murine B-cells. Curr. Top. Microbiol. Immunol. 194, 247-255.
60. Giri, D. K. and Aggarwal, B. B. ( 1998) Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J. Biol. Chem. 273, 14008-14014.
61. Bharti, A. C., Donato, N., Singh, S., and Aggarwal, B. B. ( 2003) Curcumin (diferuloylmethane) downregulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053-1062.
62. Anto, R. J., Mukhopadhyay, A., Denning, K., and Aggarwal, B. B. ( 2002) Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23, 143-150.
63. Mori, N., Fujii, M., Ikeda, S., Yamada, Y., Tomonaga, M., and Ballard, D. W., et al. ( 1999) Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood 93, 2360-2368.
64. Bueso-Ramos, C. E., Rocha, F. C., Shishodia, S., Medeiros, L. J., and Kantarjian, H. M., et al. ( 2004) Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia. Hum. Pathol. 35, 246-253.
65. Dorai, T., Cao, Y. C., Dorai, B., Buttyan, R., and Katz, A. E. ( 2001) Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47, 293-303.
66. Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J. Jr., and Sledge, G. W. Jr. ( 1997) Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol. Cell Biol. 17, 3629-3639.
67. Singh, S. and Aggarwal, B. B. ( 1995) Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J. Biol. Chem. 270, 24995-5000.
68. Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., and Narula, A. S., et al. ( 1999) Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J. Immunol. 163, 3474-3483.
69. Plummer, S. M., Holloway, K. A., Manson, M.M., Munks, R. J., and Kaptein, A., et al. ( 1999) Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18, 6013-6020.
70. Shishodia, S., Potdar, P., Gairola, C. G., and Aggarwal, B. B. ( 2003) Curcumin (diferuloylmethane) downregulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24, 1269-1279.
71. Shishodia, S., Amin, H. M., Lai, R., and Aggarwal, B. B. ( 2005) Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol. 70, 700-713.
72. Zheng, M., Ekmekcioglu, S., Walch, E. T., Tang, C. H., and Grimm, E. A. ( 2004) Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res. 14, 165-171.
73. Kim, K. H., Park, H. Y., Nam, J. H., Park, J. E., and Kim, J. Y., et al. ( 2005) The inhibitory effect of curcumin on the growth of human colon cancer cells (HT-29, WiDr) in vitro. Korean J. Gastroenterol. 45, 277-284.
74. Dikshit, P., Goswami, A., Mishra, A., Chatterjee, M., and Jana, N. R. ( 2006) Curcumin induces stress response, neurite outgrowth and prevent NF-kappaB activation by inhibiting the proteasome function. Neurotox. Res. 9, 29-37.
75. Yeh, C. H., Lin, Y. M., Wu, Y. C., and Lin, P. J. ( 2005) Inhibition of NF-kappa B activation can attenuate ischemia/reperfusion-induced contractility impairment via decreasing cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase expression. J. Cardiovasc. Pharmacol. 45, 301-309.
76. Wessler, S., Muenzner, P., Meyer, T. F., and Naumann, M. ( 2005) The anti-inflammatory compound curcumin inhibits Neisseria gonorrhoeae-induced NF-kappaB signaling, release of pro-inflammatory cytokines/chemokines and attenuates adhesion in late infection. Biol. Chem. 386, 481-490.
77. Xu, J., Fu, Y., and Chen, A. ( 2003) Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G20-G30.
78. Chen, A. and Xu, J. ( 2005) Activation of PPAR[gamma] by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G447-G456.
79. Zheng, S. and Chen, A. ( 2006) Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am. J. Physiol. Gastrointest. Liver. Physiol. 290, G883-G893.
80. Siddiqui, A. M., Cui, X., Wu, R., Dong, W., and Zhou, M., et al. ( 2006) The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit. Care Med. 34, 1874-1882.
81. Darnell, J. E. Jr. ( 1997) STATs and gene regulation. Science 277, 1630-1635.
82. Yu, C. L., Meyer, D. J., Campbell, G. S., Larner, A. C., and Carter-Su, C., et al. ( 1995) Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269, 81-83.
83. Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., and Darnell, J. E. Jr. ( 1998) Stat3 activation is required for cellular transformation by v-src. Mol. Cell Biol. 18, 2553-2558.
84. Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., and Zeng, Q., et al. ( 1998) Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth In vitro. J. Clin. Invest. 102, 1385-1392.
85. Carlesso, N., Frank, D. A., and Griffin, J. D. ( 1996) Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 183, 811-820.
86. Weber-Nordt, R. M., Egen, C., Wehinger, J., Ludwig, W., and Gouilleux-Gruart, V., et al. ( 1996) Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88, 809-816.
87. Bharti, A. C., Donato, N., and Aggarwal, B. B. ( 2003) Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J. Immunol. 171, 3863-3871.
88. Kim, H. Y., Park, E. J., Joe, E. H., and Jou, I. ( 2003) Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J. Immunol. 171, 6072-6079.
89. Li, W. Q., Dehnade, F., and Zafarullah, M. ( 2001) Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J. Immunol. 166, 3491-3498.
90. Natarajan, C. and Bright, J. J. ( 2002) Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J. Immunol. 168, 6506-6513.
91. Chen, W. H., Chen, Y., Cui, G. H., Gu, J. X., and Hu, D., et al. ( 2004) Effect of curcumin on STAT5 signaling pathway in primary CML cells. Zhongguo. Shi. Yan. Xue. Ye. Xue. Za. Zhi. 12, 572-576.
92. Chen, W. H., Chen, Y., Gu, J. X., and He, J. ( 2004) Effect of curcumin on STAT5 signaling molecule in K562 cells. Zhonghua. Xue. Ye. Xue. Za. Zhi. 25, 151-153.
93. Anuchapreeda, S., Thanarattanakorn, P., Sittipreechacharn, S., Chanarat, P., Limtrakul, P. ( 2006) Curcumin inhibits WT1 gene expression in human leukemic K562 cells. Acta Pharmacol. Sin. 27, 360-366.
94. Anuchapreeda, S., Limtrakul, P., Thanarattanakorn, P., Sittipreechacharn, S., and Chanarat, P. ( 2006) Inhibitory effect of curcumin on WT1 gene expression in patient leukemic cells. Arch. Pharm. Res. 29, 80-87.
95. Glienke, W., Maute, L., Wicht, J., and Bergmann, L. ( 2009) Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells. Eur. J. Cancer 45, 874-880.
96. Semsri, S., Krig, S. R., Kotelawala, L., Sweeney, C. A., and Anuchapreeda, S. ( 2011) Inhibitory mechanism of pure curcumin on Wilms' tumor 1 (WT1) gene expression through the PKCalpha signaling pathway in leukemic K562 cells. FEBS Lett. 585, 2235-2242.
97. Nakamura, K., Yasunaga, Y., Segawa, T., Ko, D., and Moul, J. W., et al. ( 2002) Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int. J. Oncol. 21, 825-830.
98. Dorai, T., Gehani, N., and Katz, A. ( 2000) Therapeutic potential of curcumin in human prostate cancer-I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells. Prostate Cancer Prostatic Dis. 3, 84-93.
99. Ciolino, H. P., Daschner, P. J., Wang, T. T., and Yeh, G. C. ( 1998) Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem. Pharmacol. 56, 197-206.
100. Rinaldi, A. L., Morse, M. A., Fields, H. W., Rothas, D. A., and Pei, P, et al. ( 2002) Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7, 8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa. Cancer Res. 62, 5451-5456.
101. Peled, A., Wald, O., and Burger, J. Development of novel CXCR4-based therapeutics. Expert Opin. Investig. Drugs. 21, 341-353.
102. Skommer, J., Wlodkowic, D., and Pelkonen, J. ( 2007) Gene-expression profiling during curcumin-induced apoptosis reveals downregulation of CXCR4. Exp. Hematol. 35, 84-95.
103. Sameermahmood, Z., Balasubramanyam, M., Saravanan, T., and Rema, M. ( 2008) Curcumin modulates SDF-1alpha/CXCR4-induced migration of human retinal endothelial cells (HRECs). Invest. Ophthalmol. Vis. Sci. 49, 3305-3311.
104. Bachmeier, B. E., Mohrenz, I. V., Mirisola, V., Schleicher, E., and Romeo, F., et al. ( 2008) Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. Carcinogenesis 29, 779-789.
105. Kunnumakkara, A. B., Diagaradjane, P., An P., Harikumar, K. B., and Deorukhkar, A., et al. ( 2009) Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int. J. Cancer 125, 2187-2197.
106. Chen, A. and Zheng, S. ( 2008) Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappaB and ERK signalling. Br. J. Pharmacol. 153, 557-567.
107. Chen, Y. W., Yan, W. H., Wang, M. Y., Chang, H. H., and Yen-Ping, and Kuo, M. (2012) Curcumin Inhibits thrombin-stimulated connective tissue growth factor (CTGF/CCN2) production through JNK suppression in human gingival fibroblasts. J. Periodontol. [Epub ahead of print]
108. Ahmed, K. M., Cao, N., and Li, J. J. ( 2006) HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer. Anticancer Res. 26, 4235-4243.
109. Lev-Ari, S., Starr, A., Vexler, A., Karaush, V., and Loew, V., et al. ( 2006) Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res. 26, 4423-4430.
110. Astsaturov, I., Cohen, R. B., and Harari, P. ( 2006) Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer. Expert Rev. Anticancer Ther. 6, 1179-1193.
111. Dorai, T., Gehani, N., and Katz, A. ( 2000) Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Mol. Urol. 4, 1-6.
112. Verma, S. P. and Goldin, B. R. ( 2003) Copper modulates activities of genistein, nitric oxide, and curcumin in breast tumor cells. Biochem. Biophys. Res. Commun. 310, 104-108.
113. Yan, G., Graham, K., and Lanza-Jacoby, S. (2012) Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells. Mol. Carcinog. doi: 10.1002/mc.21875.
114. Rowe, D. L., Ozbay, T., O'Regan, R. M., and Nahta, R. ( 2009) Modulation of the BRCA1 protein and induction of apoptosis in triple negative breast cancer cell lines by the polyphenolic compound curcumin. Breast Cancer (Auckl) 3, 61-75.
115. Mohan, R., Sivak, J., Ashton, P., Russo, L. A., and Pham, B. Q., et al. ( 2000) Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J. Biol. Chem. 275, 10405-10412.
116. Shao, Z. M., Shen, Z. Z., Liu, C. H., Sartippour, M. R., and Go, V. L., et al. ( 2002) Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int. J. Cancer 98, 234-2340.
117. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., and Ullrich, A., et al. ( 1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182.
118. Korutla, L. and Kumar, R. ( 1994) Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim. Biophys. Acta 1224, 597-600.
119. Korutla, L., Cheung, J. Y., Mendelsohn, J., and Kumar, R. ( 1995) Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 16, 1741-1745.
120. Hong, R. L., Spohn, W. H., and Hung, M. C. ( 1999) Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clin. Cancer Res. 5, 1884-1891.
121. Tikhomirov, O. and Carpenter, G ( 2003) Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation. Cancer Res. 63, 39-43.
122. Yang, X., Thomas, D. P., Zhang, X., Culver, B. W., and Alexander, B. M., et al. ( 2006) Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler. Thromb. Vasc. Biol. 26, 85-90.
123. Masamune, A., Suzuki, N., Kikuta, K., Satoh, M., and Satoh, K., et al. ( 2006) Curcumin blocks activation of pancreatic stellate cells. J. Cell Biochem. 97, 1080-1093.
124. Zhou, Y., Zheng, S., Lin, J., Zhang, Q. J., and Chen, A. ( 2007) The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro. Lab. Invest. 87, 488-498.
125. Park, J. I., Lee, M. G., Cho, K., Park, B. J., and Chae, K. S., et al. ( 2003) Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene 22, 4314-4332.
126. Gaedeke, J., Noble, N. A., and Border, W. A. ( 2004) Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells. Kidney Int. 66, 112-120.
127. Hu, Y., Liang, H., Du, Y., Zhu, Y., and Wang X. (2010) Curcumin inhibits transforming growth factor-beta activity via inhibition of Smad signaling in HK-2 cells. Am. J. Nephrol. 31, 332-341.
128. Song, K., Peng, S., Sun, Z., Li, H., and Yang, R. (2011) Curcumin suppresses TGF-beta signaling by inhibition of TGIF degradation in scleroderma fibroblasts. Biochem. Biophys. Res. Commun. 411, 821-825.
129. Gururaj, A. E., Belakavadi, M., Venkatesh, D. A., Marme, D., and Salimath, B. P. ( 2002) Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem. Biophys. Res. Commun. 297, 934-942.
130. Kunnumakkara, A. B., Guha, S., Krishnan, S., Diagaradjane, P., Gelovani, J., et al. ( 2007) Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 67, 3853-3861.
131. Lin, Y. G., Kunnumakkara, A. B., Nair, A., Merritt, W. M., and Han, L. Y., et al. ( 2007) Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin. Cancer Res. 13, 3423-3430.
132. Kim, D. C., Kim, S. H., Choi, B. H., Baek, N. I., and Kim, D., et al. ( 2005) Curcuma longa extract protects against gastric ulcers by blocking H2 histamine receptors. Biol. Pharm. Bull. 28, 2220-2224.
133. Hidaka, H., Ishiko, T., Furuhashi, T., Kamohara, H., and Suzuki, S., et al. ( 2002) Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95, 1206-1214.
134. Dyer, J. L., Khan, S. Z., Bilmen, J. G., Hawtin, S. R., and Wheatley, M., et al. ( 2002) Curcumin: a new cell-permeant inhibitor of the inositol 1, 4, 5-trisphosphate receptor. Cell Calcium 31, 45-52.
135. Elsharkawy, A. M., Oakley, F., and Mann, D. A. ( 2005) The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10, 927-939.
136. Nan, B., Lin, P., Lumsden, A. B., Yao, Q., and Chen, C. ( 2005) Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Thromb. Res. 115, 417-426.
137. Bush, J. A., Cheung, K. J. Jr., and Li, G. ( 2001). Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp. Cell Res. 271, 305-314.
138. Dou, X., Fan, C., Wo, L., Yan, J., and Qian, Y., et al. ( 2008) Curcumin up-regulates LDL receptor expression via the sterol regulatory element pathway in HepG2 cells. Planta Med. 74, 1374-1379.
139. Lim, J. H. and Kwon, T. K. Curcumin inhibits phorbol myristate acetate (PMA)-induced MCP-1 expression by inhibiting ERK and NF-kappaB transcriptional activity. Food Chem. Toxicol. 48, 47-52.
140. Abe, Y., Hashimoto, S., and Horie, T. ( 1999) Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol. Res. 39, 41-47.
141. Aggarwal, B. B., Schwarz, L., Hogan, M. E., and Rando, R. F. ( 1996) Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells. Cancer Res. 56, 5156-5164.
142. Tucker, S. J., Rae, C., Littlejohn, A. F., Paul, A., and MacEwan, D. J. ( 2004) Switching leukemia cell phenotype between life and death. Proc. Natl. Acad. Sci. USA 101, 12940-12945.
143. Estrov, Z., Kurzrock, R., Pocsik, E., Pathak, S., and Kantarjian, H. M., et al. ( 1993) Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. J. Exp. Med. 177, 763-774.
144. Sugarman, B. J., Lewis, G. D., Eessalu, T. E., Aggarwal, B. B., and Shepard, H. M. ( 1987) Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Cancer Res. 47, 780-786.
145. Chapekar, M. S., Huggett, A. C., and Thorgeirsson, S. S. ( 1989) Growth modulatory effects of a liver-derived growth inhibitor, transforming growth factor beta 1, and recombinant tumor necrosis factor alpha, in normal and neoplastic cells. Exp. Cell Res. 185, 247-257.
146. Borset, M., Waage, A., Brekke, O. L., and Helseth, E. ( 1994) TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line. Eur. J. Haematol. 53, 31-37.
147. Hsu, S. M., Hsu, P. L. ( 1990) Lack of effect of colony-stimulating factors, interleukins, interferons, and tumor necrosis factor on the growth and differentiation of cultured Reed-Sternberg cells. Comparison with effects of phorbol ester and retinoic acid. Am. J. Pathol. 136, 181-189.
148. Aggarwal, B. B. ( 2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3, 745-756.
149. Fu, Y., Zheng, S., Lin, J., Ryerse, J., and Chen, A. ( 2008) Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol. Pharmacol. 73, 399-409.
150. Kuhad, A. and Chopra, K. ( 2007) Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur. J. Pharmacol. 576, 34-42.
151. Dinarello, C. A. ( 2006) The paradox of pro-inflammatory cytokines in cancer. Cancer Metastasis Rev. 25, 307-313.
152. Cho, J. W., Lee, K. S., and Kim, C. W. ( 2007) Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int. J. Mol. Med. 19, 469-474.
153. Ranjan, D., Chen, C., Johnston, T. D., Jeon, H., and Nagabhushan, M. ( 2004) Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling. J. Surg. Res. 121, 171-177.
154. Kobayashi, T., Hashimoto, S., and Horie, T. ( 1997) Curcumin inhibition of dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem. Pharmacol. 54, 819-824.
155. Cohen, A. N., Veena, M. S., Srivatsan, E. S., and Wang, M. B. ( 2009) Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase. Arch. Otolaryngol. Head. Neck Surg. 135, 190-197.
156. Wang, X., Wang, Q., Ives, K. L., and Evers, B. M. ( 2006) Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells. Clin. Cancer Res. 12, 5346-5355.
157. Fahey, A. J., Adrian Robins, R., and Constantinescu, C. S. ( 2007) Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells. J. Cell. Mol. Med. 11, 1129-1137.
158. Grandjean-Laquerriere, A., Antonicelli, F., Gangloff, S. C., Guenounou, M., and Le Naour, R. ( 2007) UVB-induced IL-18 production in human keratinocyte cell line NCTC 2544 through NF-kappaB activation. Cytokine 37, 76-83.
159. Reddy, S. and Aggarwal, B. B. ( 1994) Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett. 341, 19-22.
160. Hasmeda, M. and Polya, G. M. ( 1996) Inhibition of cyclic AMP-dependent protein kinase by curcumin. Phytochemistry 42, 599-605.
161. Leu, T. H., Su, S. L., Chuang, Y. C. and Maa, M. C. ( 2003) Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity. Biochem. Pharmacol. 66, 2323-2331.
162. Jurrmann, N., Brigelius-Flohe, R., and Bol, G. F. ( 2005) Curcumin blocks interleukin-1 (IL-1) signaling by inhibiting the recruitment of the IL-1 receptor-associated kinase IRAK in murine thymoma EL-4 cells. J Nutr 135, 1859-1864.
163. Rajasingh, J., Raikwar, H. P., Muthian, G., Johnson, C., and Bright, J. J. ( 2006) Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia. Biochem. Biophys. Res. Commun. 340, 359-368.
164. Kim, G. Y., Kim, K. H., Lee, S. H., Yoon, M. S., and Lee, H. J., et al. ( 2005) Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J. Immunol. 174, 8116-8124.
165. Rafiee, P., Nelson, V. M., Manley, S., Wellner, M., and Floer, M., et al. ( 2009) Effect of curcumin on acidic pH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET-1A): role of PKC, MAPKs, and NF-kappaB. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G388-G398.
166. Johnson, S. M., Gulhati, P., Arrieta, I., Wang, X., and Uchida, T., et al. ( 2009) Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer Res. 29, 3185-3190.
167. Shinojima, N., Yokoyama, T., Kondo, Y., and Kondo, S. ( 2007) Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 3, 635-637.
168. Ramachandran, C., Rodriguez, S., Ramachandran, R., Raveendran Nair, P. K., and Fonseca, H., et al. ( 2005) Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res. 25, 3293-3302.
169. Gururajan, M., Dasu, T., Shahidain, S., Jennings, C. D., and Robertson, D. A., et al. ( 2007) Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth. J. Immunol. 178, 111-121.
170. Seger, R. and Krebs, E. G. ( 1995) The MAPK signaling cascade. FASEB J. 9, 726-735.
171. Cowley, S., Paterson, H., Kemp, P., and Marshall, C. J. ( 1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77, 841-852.
172. Minden, A., Lin, A., McMahon, M., Lange-Carter, C., and Derijard, B., et al. ( 1994) Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266, 1719-1723.
173. Bode, A. M. and Dong, Z. ( 2000) Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol. 1, 181-188.
174. Bode, A. M. and Dong, Z. ( 2003) Mitogen-activated protein kinase activation in UV-induced signal transduction. Sci. STKE 2003, RE2.
175. Kallunki, T., Su, B., Tsigelny, I., Sluss, H. K., and Derijard, B, et al. ( 1994) JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8, 2996-3007.
176. Salh, B., Assi, K., Templeman, V., Parhar, K., and Owen, D., et al. ( 2003) Curcumin attenuates DNB-induced murine colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G235-G243.
177. Kim, D. H., Sarbassov, D. D., Ali, S. M., King, J. E., and Latek, R. R., et al. ( 2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175.
178. Wullschleger, S., Loewith, R., and Hall, M. N. ( 2006) TOR signaling in growth and metabolism. Cell 124, 471-484.
179. Beevers, C. S., Li, F., Liu, L., and Huang, S. ( 2006) Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. Int. J. Cancer 119, 757-764.
180. Beevers, C. S., Chen, L., Liu, L., Luo, Y., and Webster, N. J., et al. ( 2009) Curcumin disrupts the Mammalian target of rapamycin-raptor complex. Cancer Res. 69, 1000-1008.
181. Kamath, R., Jiang, Z., Sun, G., Yalowich, J. C., and Rajasekaran, B. ( 2007) c-Abl kinase regulates curcumin-induced cell death through activation of JNK. Mol. Pharmacol. 71, 61-72.
182. Subbaramaiah, K. and Dannenberg, A. J. ( 2003) Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol. Sci. 24, 96-102.
183. Chen, H., Zhang, Z. S., Zhang, Y. L., and Zhou, D. Y. ( 1999) Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res. 19, 3675-3680.
184. Plummer, S. M., Hill, K. A., Festing, M. F., Steward, W. P., and Gescher, A. J., et al. ( 2001) Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol. Biomarkers Prev. 10, 1295-1299.
185. Hong, J., Bose, M., Ju, J., Ryu, J. H., and Chen, X., et al. ( 2004) Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25, 1671-1679.
186. Menon, L. G., Kuttan, R., and Kuttan, G. ( 1995) Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett. 95, 221-225.
187. Menon, L. G., Kuttan, R., and Kuttan, G. ( 1999) Anti-metastatic activity of curcumin and catechin. Cancer Lett. 141, 159-165.
188. Banerji, A., Chakrabarti, J., Mitra, A., and Chatterjee, A ( 2004) Effect of curcumin on gelatinase A (MMP-2) activity in B16F10 melanoma cells. Cancer Lett. 211, 235-242.
189. Hong, J. H., Ahn, K. S., Bae, E., Jeon, S. S., and Choi, H. Y. ( 2006) The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis. 9, 147-152.
190. Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., and Newman, R. A., et al. ( 2005) Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin. Cancer Res. 11, 7490-7498.
191. Chan, M. M., Huang, H. I., Fenton, M. R., and Fong, D. ( 1998) In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem. Pharmacol. 55, 1955-1962.
192. Chen, X., Hasuma, T., Yano, Y., Yoshimata, T., and Morishima, Y., et al. ( 1997) Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin. Anticancer Res. 17, 2555-2564.
193. Kang, H. M., Son, K. H., Yang, D. C., Han, D. C., and Kim, J. H., et al. ( 2004) Inhibitory activity of diarylheptanoids on farnesyl protein transferase. Nat. Prod. Res. 18, 295-299.
194. Ohene-Abuakwa, Y., Noda, M., Perenyi, M., Kobayashi, N., and Kashima, K., et al. ( 2000) Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer. J. Pathol. 192, 433-439.
195. Iademarco, M. F., Barks, J. L., and Dean, D. C. ( 1995) Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J. Clin. Invest. 95, 264-271.
196. Kumar, A., Dhawan, S., Hardegen, N. J., and Aggarwal, B. B. ( 1998) Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. Biochem. Pharmacol. 55, 775-783.
197. Gupta, B. and Ghosh, B. ( 1999) Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int. J. Immunopharmacol. 21, 745-757.
198. Ray, S., Chattopadhyay, N., Mitra, A., Siddiqi, M., and Chatterjee, A. ( 2003) Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. J. Environ. Pathol. Toxicol. Oncol. 22, 49-58.
199. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., and Pfeffer, L. M., et al. ( 1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85.
200. Romashkova, J. A. and Makarov, S. S. ( 1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401, 86-90.
201. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., and Juo, P., et al. ( 1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868.
202. Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., and Franke, T. F., et al. ( 1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321.
203. Rommel, C., Clarke, B. A., Zimmermann, S., Nunez, L., and Rossman, R., et al. ( 1999) Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1741.
204. Squires, M. S., Hudson, E. A., Howells, L., Sale, S., and Houghton, C. E., et al. ( 2003) Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem. Pharmacol. 65, 361-376.
205. Woo, J. H., Kim, Y. H., Choi, Y. J., Kim, D. G., and Lee, K. S., et al. ( 2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 24, 1199-1208.
206. Chaudhary, L. R. and Hruska, K. A. ( 2003) Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. J. Cell Biochem. 89, 1-5.
207. Hussain, A. R., Al-Rasheed, M., Manogaran, P. S., Al-Hussein, K. A., and Platanias, L. C., et al. ( 2006) Curcumin induces apoptosis via inhibition of PI3′-kinase/AKT pathway in acute T cell leukemias. Apoptosis 11, 245-254.
208. Collett, G. P. and Campbell, F. C. ( 2006) Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells. Carcinogenesis 27, 1285-1291.
209. Busquets, S., Carbo, N., Almendro, V., Quiles, M. T., and Lopez-Soriano, F. J., et al. ( 2001) Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model. Cancer Lett. 167, 33-38.
210. Jee, S. H., Shen, S. C., Tseng, C. R., Chiu, H. C., and Kuo, M. L. ( 1998) Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J. Invest. Dermatol. 111, 656-661.
211. Atsumi, T., Tonosaki, K., and Fujisawa, S. ( 2006) Induction of early apoptosis and ROS-generation activity in human gingival fibroblasts (HGF) and human submandibular gland carcinoma (HSG) cells treated with curcumin. Arch. Oral Biol. 51, 913-921.
212. Skommer, J., Wlodkowic, D., and Pelkonen, J. ( 2006) Cellular foundation of curcumin-induced apoptosis in follicular lymphoma cell lines. Exp. Hematol. 34, 463-474.
213. Baldin, V., Lukas, J., Marcote, M. J., Pagano, M., and Draetta, G. ( 1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7, 812-821.
214. Diehl, J. A. ( 2002) Cycling to cancer with cyclin D1. Cancer Biol. Ther. 1, 226-231.
215. Bartkova, J., Lukas, J., Muller, H., Lutzhoft, D., and Strauss, M., et al. ( 1994) Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer. 57, 353-361.
216. Adelaide, J., Monges, G., Derderian, C., Seitz, J. F., and Birnbaum, D. ( 1995) Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br. J. Cancer 71, 64-68.
217. Caputi, M., Groeger, A. M., Esposito, V., Dean, C., and De Luca, A., et al. ( 1999) Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen. Am. J. Respir. Cell Mol. Biol. 20, 746-750.
218. Nishida, N., Fukuda, Y., Komeda, T., Kita, R., and Sando, T., et al. ( 1994) Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 54, 3107-3110.
219. Gumbiner, L. M., Gumerlock, P. H., Mack, P. C., Chi, S. G., and deVere White, R. W., et al. ( 1999) Overexpression of cyclin D1 is rare in human prostate carcinoma. Prostate 38, 40-45.
220. Mukhopadhyay, A., Banerjee, S., Stafford, L. J., Xia, C., and Liu, M., et al. ( 2002) Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21, 8852-8861.
221. Tomita, M., Kawakami, H., Uchihara, J. N., Okudaira, T., Masuda, M., et al. ( 2006) Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. Int. J. Cancer 118, 765-772.
222. Aggarwal, S., Takada, Y., Singh, S., Myers, J. N., and Aggarwal, B. B. ( 2004) Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int. J. Cancer 111, 679-692.
223. Zheng, L., Tong, Q., and Wu, C. ( 2004) Growth-inhibitory effects of curcumin on ovary cancer cells and its mechanisms. J. Huazhong. Univ. Sci. Technolog. Med. Sci. 24, 55-58.
224. Park, M. J., Kim, E. H., Park, I. C., Lee, H. C., and Woo, S. H., et al. ( 2002) Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by upregulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53. Int. J. Oncol. 21, 379-383.
225. Saha, A., Kuzuhara, T., Echigo, N., Fujii, A., and Suganuma, M., et al. (2010) Apoptosis of human lung cancer cells by curcumin mediated through up-regulation of "growth arrest and DNA damage inducible genes 45 and 153". Biol. Pharm. Bull. 33, 1291-1299.
226. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., and Parsons, R., et al. ( 1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
227. Vogelstein, B. and Kinzler, K. W. ( 1992) p53 function and dysfunction. Cell 70, 523-526.
228. Han, S. S., Chung, S. T., Robertson, D. A., Ranjan, D., and Bondada, S. ( 1999) Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin. Immunol. 93, 152-161.
229. Choudhuri, T., Pal, S., Agwarwal, M. L., Das, T., and Sa, G. ( 2002) Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett. 512, 334-340.
230. Choudhuri, T., Pal, S., Das, T., and Sa, G. ( 2005) Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem. 280, 20059-20068.
231. Liontas, A. and Yeger, H. ( 2004) Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res. 24, 987-998.
232. Anuchapreeda, S., Leechanachai, P., Smith, M. M., Ambudkar, S. V., and Limtrakul, P. N. ( 2002) Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem. Pharmacol. 64, 573-582.
233. Limtrakul, P., Anuchapreeda, S., and Buddhasukh, D. ( 2004) Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 4, 13.
234. Sreenivasan, S., Ravichandran, S., Vetrivel, U., and Krishnakumar, S. (2012) In vitro and In silico studies on inhibitory effects of curcumin on multi drug resistance associated protein (MRP1) in retinoblastoma cells. Bioinformation 8, 13-19.
235. Li, Y., Kong, D., Wang, Z., Sarkar, F. H. (2010) Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm. Res. 27, 1027-1041.
236. Sun, M., Estrov, Z., Ji, Y., Coombes, K. R., and Harris, D. H., et al. ( 2008) Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol. Cancer Ther. 7, 464-473.
237. Yang, J., Cao, Y., Sun, J., and Zhang, Y. (2010) Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells. Med. Oncol. 27, 1114-1118.
238. Sreenivasan, S., Thirumalai, K., Danda, R., and Krishnakumar, S. (2012) Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells. Curr. Eye Res. 37, 421-428.
239. Ye, M. X., Li, Y., Yin, H., and Zhang, J. (2012) Curcumin: updated molecular mechanisms and intervention targets in human lung cancer. Int. J. Mol. Sci. 13, 3959-3978.
240. Zhang, J., Du, Y., Wu, C., Ren, X., and Ti, X., et al. (2010) Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway. Oncol. Rep. 24, 1217-1223.
241. Saini, S., Arora, S., Majid, S., Shahryari, V., and Chen, Y., et al. (2011) Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev. Res. (Phila) 4, 1698-1709.
242. Mudduluru, G., George-William, J. N., Muppala, S., Asangani, I. A., and Kumarswamy, R., et al. (2011) Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci. Rep. 31, 185-197.
243. Ali, S., Ahmad, A., Banerjee, S., Padhye, S, and Dominiak, K., et al. (2010) Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res. 70, 3606-3617.